Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.
Checked against the public recordLast updated Oct 12, 2021 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Milton S. Hershey Medical Center
- Interventions being studied
- Drug: Topical lidocaine; Drug: Nebuliser solution; Drug: Nebuliser Suspension
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Diagnosis of mediastinal and/or hilar lymphadenopathy requiring endobronchial ultrasound evaluation and transbronchial needle aspiration. * Diagnosis of pulmonary disease requiring flexible bronchoscopy * Greater than 18 years of age. Exclusion Criteria: * Any intervention beyond flexible bronchoscopy and endobronchial ultrasound * Inability to tolerate bronchoscopy. * Patients that receive paralytics. * Patients with neuromuscular diseases. * Inability to consent for procedures. * Allergies to lidocaine or any other drugs used in protocol. * Existing renal insufficiency or liver disease
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Penn State Hershey Medical CenterHershey, Pennsylvania
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 12, 2021. Always confirm current availability with the study team.